SCHEMBL13762162

SCHEMBL13762162

CNc1nc2ccc(C(C)(C)C)cc2s1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.52
CSNK1D P48730 4/20 0.52
CSNK1G2 P78368 1/20 0.52
MAP3K5 Q99683 1/20 0.52
DYRK1A Q13627 4/20 0.50
KCNH2 Q12809 1/20 0.43
SCN10A Q9Y5Y9 1/20 0.43
CYP2D6 P10635 1/20 0.42
ACP1 P24666 1/20 0.42
NPC1 O15118 5/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
RAB9A P51151 4/20 0.41
LMNA P02545 3/20 0.41
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 2/20 0.41
MAPT P10636 2/20 0.41
ALOX12 P18054 2/20 0.41
KMT2A Q03164 2/20 0.41
PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11832198 0.87 DYRK1A (0.50) LDHACSNK1DCSNK1G2MAP3K5DYRK1A
SCHEMBL5683714 0.85 DYRK1A (0.68) LDHACSNK1DDYRK1ACYP2D6ACP1
SCHEMBL14648829 0.85 CSNK1D (0.51) CSNK1DCSNK1G2MAP3K5DYRK1ACYP2D6
SCHEMBL7028444 0.85 NPC1 (0.59) CSNK1DCSNK1G2MAP3K5DYRK1AKCNH2
SCHEMBL10189655 0.83 CSNK1D (0.49) CSNK1DCSNK1G2MAP3K5DYRK1ACYP2D6
SCHEMBL10189473 0.83 CSNK1D (0.49) CSNK1DCSNK1G2MAP3K5DYRK1ACYP2D6
SCHEMBL179517 0.81 MAP3K5 (0.60) LDHACSNK1DMAP3K5DYRK1ACYP2D6
SCHEMBL12829397 0.80 NPC1 (0.68) CSNK1DCSNK1G2MAP3K5DYRK1AACP1
SCHEMBL179544 0.80 DYRK1A (0.78) LDHACSNK1DMAP3K5DYRK1ANPC1
SCHEMBL13508876 0.80 NPC1 (0.63) CSNK1DCSNK1G2MAP3K5DYRK1ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7557110-B2 MAPKAP-K2; inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth; 5-[(trans-4-aminocyclohexyl)amino]-3-fluoro-6-methyl(pyrazolo[1,5-a]pyri- midin-7-yl)}(4-iodophenyl)amine TEIJIN PHARMA LIMITED (JP) 2009-07-07 US disclosed